{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:08:19Z","timestamp":1782950899661,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.intimp.2022.109155","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T19:57:08Z","timestamp":1661371028000},"page":"109155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus"],"prefix":"10.1016","volume":"111","author":[{"given":"Xiaomin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9957","key":"10.1016\/j.intimp.2022.109155_b0005","doi-asserted-by":"crossref","first-page":"1C8","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.intimp.2022.109155_b0010","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic Lupus Erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/eci.10.8","article-title":"Recent advances in the genetics of systemic lupus erythematosus","volume":"6","author":"Flesher","year":"2010","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109155_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13075-019-2029-1","article-title":"Performance of cytokine models in predicting SLE activity","volume":"21","author":"Ruchakorn","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"2 Suppl","key":"10.1016\/j.intimp.2022.109155_b0030","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.autrev.2005.04.009","article-title":"Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18","volume":"4","author":"Calvani","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2022.109155_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.coi.2015.03.005","article-title":"BAFF receptors and ligands create independent homeostatic niches for B cell subsets","volume":"34","author":"Naradikian","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2022.109155_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cytogfr.2018.12.001","article-title":"Interleukin-13: A promising therapeutic target for autoimmune disease","volume":"45","author":"Mao","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.intimp.2022.109155_b0050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/ar3349","article-title":"Cytokine disturbances in systemic lupus erythematosus","volume":"13","author":"Jacob","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.141.3.827","article-title":"Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus","volume":"141","author":"Huang","year":"1988","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cei.13566","article-title":"Variety of endosomal TLRs and Interferons (IFN-\u03b1, IFN-\u03b2, IFN-\u03b3) expression profiles in patients with SLE, SSc and MCTD","volume":"204","author":"Paradowska-Gorycka","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","article-title":"Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis","volume":"147","author":"Linker-Israeli","year":"1991","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109155_b0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/096120339500400510","article-title":"Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity","volume":"4","author":"Houssiau","year":"1995","journal-title":"Lupus."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2249.1999.00862.x","article-title":"Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)\u2013relation to Th1- and Th2-derived cytokines","volume":"116","author":"Tokano","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109155_b0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2004.02607.x","article-title":"Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?","volume":"138","author":"Capper","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109155_b0085","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.109155_b0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.intimp.2022.109155_b0095","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","article-title":"Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus","volume":"12","author":"Narumi","year":"2000","journal-title":"Cytokine"},{"issue":"Suppl5","key":"10.1016\/j.intimp.2022.109155_b0100","doi-asserted-by":"crossref","first-page":"v12","DOI":"10.1093\/rheumatology\/keaa484","article-title":"New biomarkers in SLE: from bench to bedside","volume":"59","author":"Capecchi","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.intimp.2022.109155_b0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cyto.2012.07.004","article-title":"Serum cytokine profile in patients with active lupus nephritis","volume":"60","author":"Koenig","year":"2012","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2022.109155_b0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1759720X13485503","article-title":"Biomarkers in systemic lupus erythematosus: challenges and prospects for the future","volume":"5","author":"Liu","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2022.109155_b0115","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis. Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0120","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis. Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0125","first-page":"17","article-title":"Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity","volume":"10","author":"Viallard","year":"1999","journal-title":"Eur. Cytokine Netw."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0130","first-page":"281","article-title":"Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus","volume":"8","author":"Robak","year":"1997","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0135","first-page":"51","article-title":"Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients","volume":"24","author":"Saisoong","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109155_b0140","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/jcm11071849","article-title":"CRP Serum Levels Are Associated with High Cardiometabolic Risk and Clinical Disease Activity in Systemic Lupus Erythematosus Patients","volume":"11","author":"Pesqueda-Cendejas","year":"2022","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0145","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/0961203313492578","article-title":"Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity","volume":"22","author":"Stojan","year":"2013","journal-title":"Lupus."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.semarthrit.2018.02.012","article-title":"Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus","volume":"48","author":"Kwon","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.109155_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jim.2010.04.005","article-title":"Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus","volume":"358","author":"Hanly","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2022.109155_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology","volume":"16","author":"Arend","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109155_b0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/096120339600500603","article-title":"Serum and urinary interleukin-6 in systemic lupus erythematosus","volume":"5","author":"Peterson","year":"1996","journal-title":"Lupus."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0170","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"Park","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109155_b0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/096120339300200605","article-title":"Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus","volume":"2","author":"Meijer","year":"1993","journal-title":"Lupus."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/art.1780380806","article-title":"Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity","volume":"38","author":"Suzuki","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2022.109155_b0185","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/rheumatology\/keaa540","article-title":"Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus","volume":"60","author":"du Toit","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2022.109155_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13075-018-1525-z","article-title":"IL-1 family cytokines and soluble receptors in systemic lupus erythematosus","volume":"20","author":"Italiani","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2022.109155_b0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2022.109155_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2019.11.005","article-title":"Leukemia inhibitory factor: Recent advances and implications in biotechnology","volume":"52","author":"Pinho","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.intimp.2022.109155_b0205","doi-asserted-by":"crossref","first-page":"e0156562","DOI":"10.1371\/journal.pone.0156562","article-title":"Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction","volume":"11","author":"Kanda","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0740889.x","article-title":"Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system","volume":"74","author":"Turnley","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2022.109155_b0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2015.03.044","article-title":"Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)","volume":"56","author":"Rittchen","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2022.109155_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12865-014-0041-4","article-title":"Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection","volume":"15","author":"Foronjy","year":"2014","journal-title":"BMC Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109155_b0225","doi-asserted-by":"crossref","first-page":"F595","DOI":"10.1152\/ajprenal.00634.2014","article-title":"Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c","volume":"309","author":"Yu","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2022.109155_b0230","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/ncomms6218","article-title":"LIF negatively regulates tumour-suppressor p53 through Stat3\/ID1\/MDM2 in colorectal cancers","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.109155_b0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2008.06.002","article-title":"Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression","volume":"253","author":"Nasef","year":"2008","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109155_b0240","first-page":"332","article-title":"Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity\u2013another target for chondroprotective intervention","volume":"27","author":"Bell","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109155_b0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2014.12.010","article-title":"Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients","volume":"278","author":"Levy","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109155_b0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molmed.2010.08.007","article-title":"Therapeutic potential of LIF in multiple sclerosis","volume":"16","author":"Slaets","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109155_b0255","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109155_b0260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0265","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109155_b0270","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/eji.200738104","article-title":"Human regulatory T cells and autoimmunity","volume":"38","author":"Costantino","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109155_b0275","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.4049\/jimmunol.1900604","article-title":"Leukemia Inhibitory Factor Inhibits Plasmacytoid Dendritic Cell Function and Development","volume":"204","author":"Sesti-Costa","year":"2020","journal-title":"J. Immunol."},{"issue":"31","key":"10.1016\/j.intimp.2022.109155_b0280","first-page":"191","article-title":"Research progress on the relationship between plasma cell dendritic cells and other immune cells","volume":"3","author":"Li","year":"2008","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109155_b0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/138920007780362581","article-title":"Tryptophan catabolism in IDO+ plasmacytoid dendritic cells","volume":"8","author":"Fallarino","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"7","key":"10.1016\/j.intimp.2022.109155_b0290","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109155_b0295","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.humimm.2010.06.004","article-title":"Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease","volume":"71","author":"Brugos","year":"2010","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109155_b0300","first-page":"389","article-title":"Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis","volume":"13","author":"Abediazar","year":"2019","journal-title":"Iran. J. Kidney Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:52:11Z","timestamp":1761587531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"alternative-id":["S1567576922006397"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109155","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109155"}}